Emcure Pharmaceuticals Ltd.
EMCURE
Rang in Aktien
#4327
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aktienkurs
$18.83
Marktkapitalisierung
$3.57B
Veränderung (1 Tag)
-3.02%
Veränderung (1 Jahr)
19.04%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategorie
Healthcare
Kursverlauf für Emcure Pharmaceuticals Ltd. (EMCURE)
Höchster Schlusskurs: $20.40 am 2026-10-01
Niedrigster Schlusskurs: $15.91 am 2024-07-01
Niedrigster Schlusskurs: $15.91 am 2024-07-01
Kursverlauf der Aktie von Emcure Pharmaceuticals Ltd. von 2024 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.67 | 21.65% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.66 | 31.77% |
CH
|
|
| $18.43 | -4.03% |
IN
|
